ALLEN HOLDING INC /NY
Long book
$1.01B
Q1 2026
Positions
9
Top-10 weight
100%
concentration
Last quarter
+5.1%
SPY +14.8%
Turnover
0%
of book per quarter
Strategy in plain words
auto-generated from filingsALLEN HOLDING INC /NY is a concentrated fundamental stock-picker, running a $1.01B US long book across 9 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The book barely moves quarter to quarter — a patient, low-turnover holder. Current anchor positions: COCA-COLA CO/THE, PALANTIR TECHNOLOGIES INC-A, BERKSHIRE HATHAWAY INC-CL A, PFIZER INC, PEOPLE INC.
Over the last 9 quarters its long book ran on average 1.9pp per quarter ahead of the S&P 500, beating the index in 4 of 9 quarters. We rate its filings highest-signal: new buys here are worth attention.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
+1.3%
Q2 2024
+15.7%
Q3 2024
+5.2%
Q4 2024
+13.2%
Q1 2025
+9.2%
Q2 2025
+7.5%
Q3 2025
+2.0%
Q4 2025
-2.0%
Q1 2026
+5.1%
Sector allocation
Consumer staples 45%
Financials 24%
Technology 24%
Healthcare 6%
Long book by quarter
What does ALLEN HOLDING own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| KO COCA-COLA CO/THE | Consumer staples | 6.0M | $456.3M | 45.3% | Held |
| PLTR PALANTIR TECHNOLOGIES INC-A | Technology | 1.5M | $219.4M | 21.8% | -6.3% |
| BRK/A BERKSHIRE HATHAWAY INC-CL A | Financials | 296 | $212.6M | 21.1% | -6.6% |
| PFE PFIZER INC | Healthcare | 2.0M | $56.2M | 5.6% | +31.6% |
| PPLI PEOPLE INC | Technology | 601.1K | $24.1M | 2.4% | Held |
| BAC BANK OF AMERICA CORP | Financials | 300.0K | $14.6M | 1.5% | Held |
| AFRM AFFIRM HOLDINGS INC | Financials | 230.0K | $10.5M | 1.0% | Held |
| JPM JPMORGAN CHASE & CO | Financials | 30.0K | $8.8M | 0.9% | Held |
| IBRX IMMUNITYBIO INC | Healthcare | 687.6K | $5.3M | 0.5% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 7, 2026 | 9 | $1.01B | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 10, 2026 | 9 | $1.05B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 6, 2025 | 9 | $1.06B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 7, 2025 | 10 | $1.02B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 7, 2025 | 14 | $961.1M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 10, 2025 | 14 | $911.8M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 7, 2024 | 14 | $927.1M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 8, 2024 | 14 | $800.3M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 7, 2024 | 14 | $794.6M | canonical | SEC ↗ |
Similar funds
Sanders Capital, LLCGATES FOUNDATION TRUSTEAGLE CAPITAL MANAGEMENT LLCWoodbridge Co LtdAlecta Tjanstepension OmsesidigtMubadala Investment Co PJSCH&H International Investment, LLCNewlands Management Operations LLCINVESTOR ABIndependent Franchise Partners LLPPineStone Asset Management Inc.Pentwater Capital Management LP